Open AccessProspects for the future of epidermal growth factor receptor-tyrosine kinase inhibitors in combination with bevacizumab
Author(s) -
Yasuhiro Chikaishi,
Fumihiro Tanaka,
Yohei Honda,
Masaaki Inoue,
Junichi Yoshida,
Masao Tanaka
Publication year - 2020
Publication title -
translational cancer research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.254
H-Index - 30
eISSN - 2219-6803
pISSN - 2218-676X
DOI - 10.21037/tcr.2020.01.24
Subject(s) - bevacizumab , tyrosine kinase , cancer research , pharmacology , platelet derived growth factor receptor , tyrosine kinase inhibitor , medicine , epidermal growth factor receptor , receptor tyrosine kinase , epidermal growth factor , tropomyosin receptor kinase c , oncology , receptor , growth factor , cancer , chemotherapy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom